Protagonist Therapeutics Stock Market Value
| PTGX Stock | USD 29.98 0.43 1.41% |
| Symbol | Protagonist |
Protagonist Therapeutics Price To Book Ratio
Is Protagonist Therapeutics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Protagonist Therapeutics. If investors know Protagonist will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Protagonist Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share 2.54 | Revenue Per Share 5.308 | Quarterly Revenue Growth (1.00) | Return On Assets 0.2138 | Return On Equity 0.4175 |
The market value of Protagonist Therapeutics is measured differently than its book value, which is the value of Protagonist that is recorded on the company's balance sheet. Investors also form their own opinion of Protagonist Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Protagonist Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Protagonist Therapeutics' market value can be influenced by many factors that don't directly affect Protagonist Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Protagonist Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Protagonist Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Protagonist Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Protagonist Therapeutics 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Protagonist Therapeutics' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Protagonist Therapeutics.
| 04/29/2024 |
| 05/29/2024 |
If you would invest 0.00 in Protagonist Therapeutics on April 29, 2024 and sell it all today you would earn a total of 0.00 from holding Protagonist Therapeutics or generate 0.0% return on investment in Protagonist Therapeutics over 30 days. Protagonist Therapeutics is related to or competes with Transcode Therapeutics, Cardio Diagnostics, MicroAlgo, Morningstar Unconstrained, T Rowe, Nt International, and Malaga Financial. Protagonist Therapeutics, Inc., a biopharmaceutical company, discovers and develops peptide-based therapeutic drugs to a... More
Protagonist Therapeutics Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Protagonist Therapeutics' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Protagonist Therapeutics upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 2.32 | |||
| Information Ratio | 0.0295 | |||
| Maximum Drawdown | 11.95 | |||
| Value At Risk | (4.05) | |||
| Potential Upside | 4.28 |
Protagonist Therapeutics Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Protagonist Therapeutics' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Protagonist Therapeutics' standard deviation. In reality, there are many statistical measures that can use Protagonist Therapeutics historical prices to predict the future Protagonist Therapeutics' volatility.| Risk Adjusted Performance | 0.0332 | |||
| Jensen Alpha | 0.0456 | |||
| Total Risk Alpha | (0.01) | |||
| Sortino Ratio | 0.0314 | |||
| Treynor Ratio | 0.0468 |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Protagonist Therapeutics' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Protagonist Therapeutics Backtested Returns
We consider Protagonist Therapeutics very steady. Protagonist Therapeutics maintains Sharpe Ratio (i.e., Efficiency) of 0.0036, which implies the firm had a 0.0036% return per unit of risk over the last 3 months. We have found twenty-eight technical indicators for Protagonist Therapeutics, which you can use to evaluate the volatility of the company. Please check Protagonist Therapeutics' Semi Deviation of 2.23, risk adjusted performance of 0.0332, and Coefficient Of Variation of 2293.06 to confirm if the risk estimate we provide is consistent with the expected return of 0.0088%. The company holds a Beta of 2.09, which implies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Protagonist Therapeutics will likely underperform. Protagonist Therapeutics right now holds a risk of 2.48%. Please check Protagonist Therapeutics potential upside, as well as the relationship between the accumulation distribution and period momentum indicator , to decide if Protagonist Therapeutics will be following its historical price patterns.
Auto-correlation | -0.5 |
Modest reverse predictability
Protagonist Therapeutics has modest reverse predictability. Overlapping area represents the amount of predictability between Protagonist Therapeutics time series from 29th of April 2024 to 14th of May 2024 and 14th of May 2024 to 29th of May 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Protagonist Therapeutics price movement. The serial correlation of -0.5 indicates that about 50.0% of current Protagonist Therapeutics price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.5 | |
| Spearman Rank Test | -0.18 | |
| Residual Average | 0.0 | |
| Price Variance | 0.57 |
Protagonist Therapeutics lagged returns against current returns
Autocorrelation, which is Protagonist Therapeutics stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Protagonist Therapeutics' stock expected returns. We can calculate the autocorrelation of Protagonist Therapeutics returns to help us make a trade decision. For example, suppose you find that Protagonist Therapeutics has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Protagonist Therapeutics regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Protagonist Therapeutics stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Protagonist Therapeutics stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Protagonist Therapeutics stock over time.
Current vs Lagged Prices |
| Timeline |
Protagonist Therapeutics Lagged Returns
When evaluating Protagonist Therapeutics' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Protagonist Therapeutics stock have on its future price. Protagonist Therapeutics autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Protagonist Therapeutics autocorrelation shows the relationship between Protagonist Therapeutics stock current value and its past values and can show if there is a momentum factor associated with investing in Protagonist Therapeutics.
Regressed Prices |
| Timeline |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Protagonist Therapeutics offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Protagonist Therapeutics' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Protagonist Therapeutics Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Protagonist Therapeutics Stock:Check out Protagonist Therapeutics Correlation, Protagonist Therapeutics Volatility and Protagonist Therapeutics Alpha and Beta module to complement your research on Protagonist Therapeutics. For more information on how to buy Protagonist Stock please use our How to Invest in Protagonist Therapeutics guide.Note that the Protagonist Therapeutics information on this page should be used as a complementary analysis to other Protagonist Therapeutics' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sectors module to list of equity sectors categorizing publicly traded companies based on their primary business activities.
Complementary Tools for Protagonist Stock analysis
When running Protagonist Therapeutics' price analysis, check to measure Protagonist Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Protagonist Therapeutics is operating at the current time. Most of Protagonist Therapeutics' value examination focuses on studying past and present price action to predict the probability of Protagonist Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Protagonist Therapeutics' price. Additionally, you may evaluate how the addition of Protagonist Therapeutics to your portfolios can decrease your overall portfolio volatility.
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories |
Protagonist Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.